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Abstract
Prions are self-propagating proteins involved in transmissible spongiform encephalopaties in mammals. An aberrant
conformation with amyloid-like features of a cell surface protein, termed prion protein (PrP), is thought to be the essential
component of the infectious particle, though accessory co-factor molecules such as lipids and nucleotides may be involved.
The cellular co-factors and environmental conditions implicated in PrP misfolding are not completely understood. To
address this issue, several studies have been done inducing misfolding of recombinant PrP (recPrP) into classical amyloid
structures using partially denaturing conditions. In this work, we report that misfolding of recPrP into PrP
Sc-like aggregates
can be induced by simply incubating the protein in the presence of kosmotropic salts at concentrations that are known to
retain or increase the stability of the protein. We used a simple experimental reaction (protein, buffer and salts) submitted to
agitation/incubation cycles at physiological temperature and pH. The formation of protease resistant-recPrP was time and
salt-concentration dependent and required the presence of kosmotropic anions such as F
2 or SO4
22. The molecular weights
of the protease resistant recPrP fragments are reminiscent of those found in degradation assays of bona fide PrP
Sc. The
aggregates also exhibited PrP
Sc-like ultrastructural features including rod-shape morphology under electron microscope,
high beta-sheet content and thioflavin-T positive signal. The formation of recPrP aggregates with PrP
Sc biochemical features
under conditions closer to physiological in the absence of organic co-factor molecules provides a simple setup that may
prove helpful to understand the molecular mechanism of PrP misfolding.
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Introduction
Transmissible spongiphorm encephalopaties (TSEs) are fatal and
infectious neurological maladies in mammals caused by prions. The
infectious agent is primarily composed of an aberrantly folded
glycosylated protein termed prion protein (PrP), which is mainly
expressed in the brain [1,2] . Misfolded PrP in its prion state (PrP
Sc)
acquire self-propagationfeaturestoinducethetransformationofthe
normal PrP conformation (PrP
C) into the infectious form [3]. In
vitro experiments using brain extracts from infected and uninfected
animals have shown that it is possible to harvest prions in the test
tube and recapitulate most of the biochemical and pathological
events by the so-called PMCA (protein misfolding cyclic amplifica-
tion) technology [4,5]. Despite these great advances, understanding
the molecular details of the protein conversion mechanism requires
experimental setups relying on pure and defined components
mimicking most of the features associated to prion formation.
Experiments using exclusively recombinant PrP (recPrP) have so far
failed to show infectivity in wild-type animals in a first passage [6,7].
However, highly infectious synthetic prions have been reported
using mixtures of recPrP, lipids and mouse-extracted RNA
molecules submitted to PMCA [8]. RecPrP aggregates with low
and heterogeneous infectivity were also achieved using modified
PMCA experiments in reactions containing recPrP and mixtures of
detergents (SDS and triton) [9,10]. The lack of highly infectious
material prepared with protein-only inoculates suggests that
accessory co-factor molecules may be essential for prion infectivity
in mammals [11–13].
Experimental approaches aimed to induce the conversion of
recPrP into amyloid-like aggregates with some of the features
associated to PrP
Sc have classically relied on the use of chemical
and/or physical agents promoting partial or total protein
denaturation such as guanidine hydrochloride, urea, SDS,
temperature, pH, etc. [9,14–21]. Most of these protocols yield
recPrP aggregates resembling typical amyloid fibrils. This is in
agreement with the current hypothesis that most, if not all,
proteins have intrinsically the capability to be converted into
amyloids [22]. Although PrP
Sc isolates exhibit some amyloid-like
features, they rarely form classical amyloid fibrils [23,24]. Thus it
is unclear whether the formation of large amyloid aggregates is
necessary for infectivity. RecPrP has been converted into PrP
Sc-
like aggregates when combined with lipids under physiological
conditions and in the absence of denaturants [25]. Interestingly, as
mentioned above, these same aggregates were later shown to be
infectious in wild-type mice when RNA molecules were added to
the mixture that was then subjected to PMCA cycles [8].
Salts have been previously used as a more physiological way of
inducing protein misfolding and formation of amyloids [26–29]. It
has been previously demonstrated that recPrP show a dual
behavior in the presence of stabilizing salts, which is characterized
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stabilizing effects at high concentrations according to the
Hofmeister series [30], which is a classification of ions in order
of their effect on protein solubility [31]. Sodium chloride can
stimulate formation of recPrP amyloid in a concentration
dependent manner under non-physiological conditions including
very low pH and high temperatures [29]. Here, we tested the effect
of kosmotropic/stabilizing salts on the misfolding pathway of full-
length recPrP using strictly physiological temperature and pH.
Our results show that kosmotropic anions specifically promote
formation of PrP
Sc-like aggregates in reactions containing only
protein as the main organic molecule.
Results
Kosmotropic salts induce formation of protease-resistant
aggregates of full length recPrP
Prions composed of brain-derived PrP
Sc are known to be partially
resistantto degradation byproteases[1]. WeincubatedrecPrPinthe
presence of various salts to test the formation of protease-resistant
material. In initial experiments, we found that the kosmotropic salt
ammonium fluoride (NH4F) induced the formation of recPrP
aggregates when incubated for 30 hrs using agitation/incubation
cycles. Interestingly, these aggregates exhibited partially resistant to
protease-degradation in a salt concentration-dependent manner as
shown by Western Blotting analysis (Fig. 1A). The salt concentration
at which protease-resistant recPrP (recPrP
res) was first detected was
around 300 mM. At lower concentrations we did not observe any
protease-resistant material. The main degradation fragment exhib-
ited a 16–17 kDa molecular weight, which is in agreement with the
sizes reported for unglycosylated GPI-less PrP
Sc [32]. We also
noticed that at high concentrations of salt, the signal of undigested
recPrP also increased, which may be indicative of salting-out effects
occurring duringthereactions.Byhigh speed ultracentrifugation,we
determined that about sixty percent of the total protein is aggregated
after a 24 hrs reaction, from which about twenty percent exhibited
protease-resistance (data not shown). In order to determine whether
the observed effect caused by NH4F was salt-specific, we used
sodium fluoride (NaF), another known kosmotropic agent that
promotes stabilization of structured states of most proteins, including
recPrPat high saltconcentrations [30].Interestingly, under the same
experimental conditions, NaF induced the formation of protease-
resistant recPrP species in a concentration-dependent manner with
similar sizes as those observed with NH4F( F i g .1 B ) .
PrP
Sc degradation occurs at the N-terminal region of PrP,
implying that the protease-resistant material that retains infectivity
properties is a C-terminal truncated portion of PrP [33–35]. In
order to map the topology of the protease-resistant bands observed
after incubation with NH4F, we used two different antibodies.
mAB 6D11 is known to target a region between 93–109 within
PrP of different species, including mouse. We also used the
polyclonal antibody M-20 that recognizes an epitope near the C-
terminus of PrP. All the protease-resistant fragments gave positive
signal with both antibodies, suggesting that the products exhibit a
similar mapping profile to that of PrP
Sc, and that the 16–17 kDa
species are the main proteolytic fragments upon digestion (Fig. 1C).
Faints bands corresponding to 10–12 kDa molecular weight
fragments were also detected with these antibodies.
Visible aggregation was evident at the end of the reaction in the
presence of both kosmotropic salts. To rule that formation of
Figure 1. Formation of protease-resistance recPrP aggregates (recPrP
res). A-B: RecPrP was incubated with different concentrations of NH4F
(A) and NaF (B) as described in materials and methods, followed by Western Blotting. Salts concentrations (mM) for the reactions were 0, 100, 200,
300, 400 and 500 for lanes 1, 2, 3, 4, 5 and 6, respectively. A small amount of undigested recPrP used as a marker of electrophoretical migration is
shown on lane 7 for each figure. C: Antibody mapping analysis of protease resistance fragments was performed using a 400 mM NH4F-based reaction
incubated for 24 hrs. Duplicated samples at two different dilutions (1/2 and 1/1 per left and right lane, respectively) were western-blotted using
monoclonal antibodies 6D11 and M-20. The arrow indicates the presence of oligomeric species. D: RecPrP was incubated for 0 hrs (dashed line) or
24 hrs (solid line) with 400 mM NH4F and then fluorescence emission spectra of samples in the presence of 10 uM Th-T was recorded. An emission
maximum was obtained at 491 nm when excited at 435 nm, typical of amyloid-like aggregates.
doi:10.1371/journal.pone.0031678.g001
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these aggregates with the amyloid-specific dye thioflavin T (Th-T)
[17,36]. The Th-T signal significantly increased, suggesting
formation of amyloid-like particles (Fig. 1D).
The anion and not the cation is responsible for inducing
protease-resistant recPrP
We previously observed that incubation of recPrP in the
presence of high concentrations of either NH4F or NaF led to the
formation of protease-resistant species (Fig. 1A and B), suggesting
that the kosmotropic cation ammonium is not essential for this
phenomenon. In order to determine whether the effect observed is
dependent on the anion or cation, we incubated recPrP in the
presence of different salts which differed in their kosmotropicity as
well as on the nature of the kosmotropic ion (Fig. 2). High
concentrations of sodium sulfate (Na2SO4), which has a kosmo-
tropic anion and a neutral cation produced a similar effect to those
described in Fig. 1 (Fig. 2A). However, when recPrP was incubated
at the same concentrations of sodium chloride (NaCl), no protease-
resistant species were observed (Fig. 2B), suggesting that
kosmotropic anions are essential in generating PrP
Sc-like recPrP
species. In order to further assess the specificity of kosmotropic
anions on the observed effects, we incubated recPrP in the
presence of the kosmotropic salt tetramethylammonium sulfate
((CH3)4N)2(SO4). Formation of protease-resistant recPrP was again
observed at similar salt concentrations as those described
previously (Fig. 2C). When the protein was incubated in the
presence of tetramethylammonium chloride ((CH3)4N)2(Cl), which
retains the kosmotropic cation (tetramethylammonium) but
replaces sulfate by chloride anion, there was again no formation
of protease-resistant species (Fig. 2D). These results provide strong
support for a specific role of the kosmotropic anion. In order to
rule out that formation of smaller or different protease-resistant
species non-recognized by the monoclonal antibody 6D11 may be
taking place in the reaction using ((CH3)4N)2(Cl), we analyzed the
reaction products described in Fig. 2D by silver-staining. Again,
we confirmed the absence of any detectable protease-resistant
species (Fig. 2F). Interestingly, silver staining analysis of recPrP
incubated in ((CH3)4N)2(SO4) yielded a main 16–17 kDa protease-
resistant fragment (Fig. 2E) similar to that observed by western
blots, and very faint bands corresponding to smaller 10–12 kDa
fragments, similar to those observed with the C-terminal specific
anti-PrP antibody (Fig. 1C). We did not observed fragments with
molecular weight smaller than 10 kDa under any of the conditions
tested (data not shown). To rule out an adverse effect of the salts in
the proteolytic activity of PK, we used BSA as a control and
confirmed that PK retains its proteolytic activity in the presence of
kosmotropic salts even at the highest concentrations used in our
studies (data not shown).
Time-dependent formation of recPrP
res
A time-course experiment was performed in order to evaluate
the progress of the reaction over time. We chose NH4F as the
kosmotropic salt and followed the reaction for several days by
silver staining analysis in order to provide a full spectrum of
protease-resistant fragments. The formation of recPrP
res rapidly
increased in the first hours of incubation and reached saturation
after 4–6 days (Fig. 3A). We also noticed that the intensity of the
Figure 2. Kosmotropic anions induce formation of PrP
Sc-like protease-resistant species. A–F: RecPrP was incubated with different
concentrations of sodium sulfate (Na2SO4, A), sodium chloride (NaCl, B), tetramethylammonium sulfate (((CH3)4N)2(SO4), C,E)a n d
tetramethylammonium chloride ((CH3)4N(Cl), D,F) as described in Experimental Procedures, followed by Western Blotting (A–D) or silver staining
(E,F). Salts concentrations (mM) for the reactions were 0, 100, 200, 300, 400 and 500 for lanes 1, 2, 3, 4, 5 and 6, respectively. Undigested recPrP
standard is shown on lane 7 for each figure. The arrows indicate the signal corresponding to proteainse K (PK).
doi:10.1371/journal.pone.0031678.g002
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increased in time in a similar way as those of higher sizes, but were
always a minor component. Moreover, the signal of the band
associated to undigested full length recPrP also increased with a
similar pattern. However, after several hours of reaction, this
signal remained steady, while the protease-resistant digested
products kept increasing, suggesting a more specific effect of the
salt on the formation of the PrP
Sc-like protease-resistant species.
To study the time dependency of amyloid formation and
whether its kinetics followed a seeding-nucleation model typical of
amyloids, we measured the Th-T signal as a function of time. The
formation of Th-T positive aggregates exhibited a classical
sigmoideal behavior with a lag-phase of around 15 hrs, followed
by a exponential face, reaching a maximum at around 28 hrs
(Fig. 3B) and then a small decay of the signal, probably due to
formation of Th-T-inaccessible clumps of aggregates.
Structural characterization of recPrP
res aggregates
To study the structural features of salt-induced recPrP
res
aggregates, samples were analyzed by by FT-IR spectroscopy
and compared it to soluble recPrP and brain-purified PrP27-30.
Both recPrP
res aggregates and PrP27-30 showed a main
absorbance peak at around 1639 cm
21 which is indicative of
predominant beta-sheet secondary structure, while soluble recPrP
exhibited high alpha-helical content, peaking at around
1658 cm
21 (Fig. 4A).
The ultra-structural morphology of protease-resistant recPrP
aggregates (same as those used for FT-IR) assessed by TEM
exhibited features similar to those observed with highly purified
PrP27-30 obtained from the brain of prion infected animals
(Fig. 4B). In both samples, we observed rod-shaped structures
which formed large clumps of aggregates. Little or no classical
amyloid fibrils were seen in any of the preparations. This is
another indication that our protocol to induce misfolding of
recPrP result in structures more similar to brain-derived PrP
Sc
than protocols involving kaotropic agents which lead to the
formation of classical amyloid fibrils [14–21].
Citotoxicity of salt-induced recPrP
res
We next sought to test whether the protease-resistant fragments
generated in the presence of salts acquire toxic features against
Figure 3. Time-dependent formation of recPrP
res. A: RecPrP was aggregated in 400 mM NH4F for different times: 0 hrs (lane 1), 3 hrs (lane 2),
10 hrs (lane 3), 24 hrs (lane 4), 72 hrs (lane 5) and 144 hrs (lane 6) and the recPrP
res product was analyzed by silver staining. PK signal is highlighted
by the solid arrow. The undigested recPrP signal is indicated by the dashed arrow. In all panels, samples were digested using PK at 1/10 PK/recPrP
ratio for 1 hrs at 37uC and then subjected to silver staining. Molecular weights markers (kDa) are shown on the left side. B: A similar reaction was
followed by the increase in Th-T signal in time. Each time point corresponds to the mean and standard error of 3 independent replicates. The points
fit very well to a sigmoidal curve (dashed line).
doi:10.1371/journal.pone.0031678.g003
Figure 4. Structural properties of recPrP aggregates. A: Buffer
and baseline-corrected FTIR spectra of PK-treated salt-induced recPrP
aggregates (solid line) compared to those of soluble recPrP (dashed
line) and PrP27-30 purified from the brain of mouse infected with RML
prions (dotted line). FTIR spectra were obtained using the conditions
described in Experimental Procedures. B: To study the morphology of
the PK-treated recPrP aggregates, samples were loaded onto EM grids,
stained with silver nitrate and visualized under TEM. Representative
images for both PrP27-30 and recPrP
res aggregates are shown at two
different magnifications (see the magnification bars).
doi:10.1371/journal.pone.0031678.g004
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experiments adding directly the recPrP incubated with salts onto
the cells. However, NaF per se was highly toxic to cells (data not
shown). Thus, we first removed the salt by extensive dialysis before
adding the proteins to the cell cultures. Under these conditions we
observed high levels of toxicity of recPrP
res as measured by the
MTT cell viability assay (Fig. 5). The citotoxic activity occurred at
very low concentrations of recPrP
res comparable to those
produced by PrP27-30 purified from the brain of prion infected
animals. These concentrations are 1000-times lower than those
used with small PrP fragments polymerized into amyloid fibrils
[37,38]. As expected, soluble recPrP and the dialysis buffer gave a
near-to-zero toxicity (Fig. 5).
Discussion
PrP misfolding is a central event in the pathogenesis of prion
diseases. The mechanism responsible for the PrP
C to PrP
Sc
conversion and the potential role of accessory molecules in this
process are not completely understood [12,39]. Several in vitro
models have been proposed to study the mechanism of prion
conversion. Among them extensive studies have been done using
recPrP forced to aggregate into amyloid fibrils by using partially
denaturing conditions, including chemical (guanidine hydrochlo-
ride, urea, SDS, etc.) and/or physical denaturants (temperature,
pH, pressure, etc.) [14–21]. In some of these studies recPrP
aggregates displayed various biochemical and even infectious
properties of PrP
Sc [6,7,10,17]. All of these experimental
approaches rely on the assumption that partially unfolding states
of the protein are directly involved in the amyloid formation
pathway [22,40]. In this work, we aimed to test whether recPrP
can be folded into a PrP
Sc-like conformation by more physiological
conditions, and in the absence of any organic molecule, using
exclusively stabilizing salts.
Protein-stabilizing salts have been classically shown to affect
fibril formation in many amyloid systems [27,29,41–45]. In most
cases, the lag phase of the process is accelerated at high
concentrations of anions in an ion-specific manner that follows
the Hofmeister series [26,27,29,42–44], indicating a predomi-
nance of protein-water-ion interactions [43]. The Hofmeister
series provides a general classification of ions which proceeds
according to their effect on protein solubility [31]. Generally, ions
are arranged from highly stabilizing (kosmotropic) to destabilizing














+2 for cations, among others [31]. Aggregation of recPrP
in the presence of the protein stability-wise neutral salt NaCl was
reported at very low pHs and high temperatures [29]. In addition,
recPrP stability at physiological conditions seems to follow the
Hofmeister series order at high salt concentrations [30]. In this
work, we found that at physiological pH and temperature, high
concentrations of kosmotropic anions specifically promoted
formation of protease-resistant aggregates that are reminiscent to
those formed with bona-fide prions. The protease resistance
fragments exhibited an approximated size of ,16–17 kDa (Fig. 1),
which is in agreement with sizes reported for PrP27–30
(subtracting the weights associated to GPI anchor and glycans)
[1,32]. Smaller fragments with molecular weights in the range of
10–12 kDa, reminiscent of the size of those observed in some
TSEs cases [46–48] were also detected albeit at much lower
quantity (Fig. 1C, 3A). Kosmotropic cations did not produce
detectable protease-resistant fragments of any size (Fig. 2B, D and
F). Interestingly, we observed that NH4F induced recPrP
misfolding at lower salt concentrations compared to NaF, though
the anion is the same in both cases (Fig. 1). The more stabilizing
cation NH4
+ may exert a synergistic effect on recPrP misfolding
when coupled with kosmotropic anions. A similar but less clear
effect was also observed with SO4 when coupled to (CH3)4N
+ but
not with Na
+ (Fig. 2). More experiments are needed to clarify this.
Although the salts used in this study are not considered denaturing
agents, they may have some impact on the activity of the protease
used in our studies. To rule out any significant effect of the salt on
the protease activity, we did a control digestion assay of BSA in the
presence of PK. We observed that PK degradation ability was not
affected by the salt concentrations used in our assay (data not
shown). This is not surprising considering that PK is completely
active at high concentrations of NaCl [49]. Additional evidence to
rule out an effect of the salt in protease activity comes from our
time-course experiments. As showed in figure 3A at short times of
incubation with salt, only a faint signal of protease-resistant recPrP
is observed, despite the fact that the PK digestion conditions,
including protease, PrP and salt concentrations, were the same as




res aggregates exhibited classical features associated
to amyloids such as an increase in Th-T fluorescence emission,
sigmoideal time-dependent aggregation mechanism and changes
in secondary structure leading to higher contents of beta-sheet. We
were not able to observe formation of typically well-defined
amyloid fibers by TEM analysis. Classical amyloid fibrils are
typically formed by using partially denaturing conditions, as it has
been shown for recPrP in various reports [6,14,17,18,50,51]. On
the other hand, bona fide PrP
Sc isolated from the brains of prion
infected wild-type animals usually exhibits relatively low content of
Figure 5. RecPrP
res aggregates are similarly neurotoxic as
PrP27-30. RecPrP
res aggregates were produced by incubation for
24 hrs with 400 mM NaF followed by PK-digestion for 1 hrs at 37uC.
100, 50 and 25 nM of dialyzed recPrP
res aggregates were added to the
medium of 1610
5 N2A neuroblastoma cells and cell viability was
measured after 24 hrs of incubation using the MTT assay. As a negative
control, the same volume of PBS was added to the well (control).
Purified PrP27-30 from RML infected mice brain, soluble recPrP (recPrP)
and the reaction buffer without protein (buffer) were also assayed as
controls. All experiments were done in triplicate and the values
correspond to the average 6 standard error. The reduction of cell
viability produced by addition of recPrP
res or PrP
Sc was highly
significantly (P,0.001) different from soluble recPrP and the buffer
control, as determined by student t-test.
doi:10.1371/journal.pone.0031678.g005
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the aggregates consisting of clumps of rod-like structures was very
similar between PrP
Sc and salt-induced recPrP
res (Fig. 4B). It is
possible that kosmotropes-induced aggregates follow a different
aggregation pathway than those formed under partially denatur-
ant conditions, by for instance retaining some native-like structure.
Amyloids generated under non-denaturing conditions have been
previously shown to exhibit such features [40].
The mechanism by which kosmotropic salts induce PrP
Sc-like
properties in recPrP is not known, but may involve a specific
interaction with the protein promoting conformational changes
(Fig. 6). Salts have been previously shown to be required by PrP
Sc
in order to exhibit full protease-resistance features [49]. One
potential scenario to explain recPrP partial resistance to
proteloytic degradation observed upon incubation with kosmo-
tropic anions may be simply due to electrostatic binding of ions to
the highly basic N-terminal region blocking the access to cleavage
sites by the protease (Fig. 6A). However we consider this scenario
unlikely since chloride ion did not exert a significant effect (Fig. 2B,
D and F). Moreover, positive charges are spread all over the N-
terminal domain, which should cause an overall, unspecific
protection against degradation. The observed protease resistance
of the reminder C-terminal domain is also not accounted by this
model. We also rule out a high specificity for the kosmotropic
anion due to the high salts concentrations required to observe the
protease-resistant bands and the fact that different kosmotropic
anions produced similar results. Accordingly, stabilizing salts may
promote PrP misfolding by increasing the local concentration of
the protein through salting-out mechanisms (Fig. 6B). Under this
scenario, folding intermediates or even PrP
Sc-like particles
originally present at very low concentrations would increase their
effective concentration, accelerating the nucleation and seeding
processes. As suggested elsewhere, fibril formation can be
conceived as a specific case of salting-out in a similar way as
general protein crystallization proceeds [43]. However, salting-out
by itself may not be the only mechanism involved in generating
PrP
Sc-like aggregates, because kosmotropic cations were not able
to promote protease-resistance (Fig. 2D, F) though visible
aggregation was clear upon reactions at high salt concentrations
(data not shown). Soluble recPrP is known to be thermodynam-
ically stabilized at high concentrations of kosmotropic anions such
as fluoride and sulfate, whereas chloride induces a rather
destabilizing effect [30]. In our work, these two kosmotropic
anions strongly stimulated formation of protease-resistant aggre-
gates, whereas chloride, even when bound to a highly stabilizing
cation, did not have a detectable effect. Sulfate and phosphate
anions decorating the surface of certain macromolecules such as
heparan-sulfate and polynucleotides have been proposed to play a
role in PrP conversion [39,52–54]. Interestingly, these macromol-
ecules have also been proposed to serve as scaffolds that
concentrate PrP molecules on its surface in addition to providing
structure-compatible negatively charged groups, thereby acting as
a potential catalyst for PrP
Sc formation [53,55–58]. Our work is
consistent with those reports, suggesting that increased local
Figure 6. Potential mechanisms for recPrP aggregation induced by kosmotropic salts. The soluble monomeric recPrP is represented as a
two-domain protein, C-terminal globular domain (triangle) containing a large proportion of alpha-helical structure and the natively-unfolded N-
terminal domain (solid line). Misfolded recPrP acquires intermolecular beta-sheet secondary structure in the natively unfolded region 90–145
(represented as a dark gray horizontal rectangle). The structural fate of the C-terminal domain is unclear, but most likely involves a conformational
rearrangement (represented as a dark blue rectangle). The kosmotropic anions are represented by the blue circles. The dotted arrows indicate a
misfolding process, while the solid arrows represent the protease digestion reaction (PK). Three putative models to explain the effect of the salt on
inducing the formation of recPrP
res are proposed. A: Binding of kosmotropic anions may occlude protease cleavage sites within the N-terminal
domain of PrP. However, this model per se does not account for the partial resistance to proteolytic degradation of the whole C-terminal domain as
well as for the structural changes induced by salt. B: A salting-out-like mechanism locally increases PrP concentration in a native-like conformation,
followed by either an induction or acceleration of misfolding to form intermolecular beta-sheets giving rise to PrP
Sc-like aggregates. C: A combined
effect of high concentrations of kosmotropic anions that partially salt-out recPrP in a close-to-native fold from the bulk solution, along with specific
anion binding to PrP that further stabilizes the N-terminal domain induce a protease-resistant recPrP conformation with PrP
Sc features.
doi:10.1371/journal.pone.0031678.g006
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may be critical for the conversion process. In addition, the
acquisition of protease-resistance in part of the natively unfolded
N-terminal domain may be a manifestation of disorder-to-order
structural transitions within the region that are induced and/or
stabilized by interaction with stabilizing anions (Fig. 6C). The
electrostatic stabilization of the unstructured PrP region (residues
,90–125) may be critical for misfolding due to its highly basic
nature rather than in the globular C-terminal domain (residues
,125–230) which is more neutral at pH 7 [59]. Upon conversion,
the globular domain may undergo structural rearrangement
through an independent pathway though this is still matter of
debate. A recent report provides evidence for a major refolding
within this region of PrP
Sc [60].
Our studies demonstrate that recPrP aggregates exhibiting
PrP
Sc-like biochemical properties can be readily formed using
stabilizing salts. Synthetic infectious prions have been achieved
using recPrP, lipids and mouse-derived RNA molecules [8].
Highly variable and low infectivity was also reported using recPrP
in a mixture of detergents and saline buffer [10]). The formation of
prions made out of strictly protein in buffer without organic
additives has not been achieved so far. Our findings present a
system in which recPrP misfolding with features associated to
PrP
Sc can be induced only by varying the concentration of
kosmotropic anions in a close-to-physiological experimental setup.
Infectivity studies with these samples are currently ongoing. If
these studies show the generation of infectivity, salts may represent
the simplest ‘‘co-factor’’ molecule required for prion generation.
Materials and Methods
Full length recombinant mouse PrP (recPrP) cloning,
expression and purification
DNA primers (forward 59-CTGTCTAGAATGAAAAAGCG-
GCCAAAGCCTGG-39 and reverse 59 GAGCTCGAGTTAG-
GATCTTCTCCCGTCGTAATA 39) with restriction sites for
Xba I (forward primer) and Xho I (reverse primer) were
synthesized and used to amplify by PCR the murine prnp gene
23–230 from C57 mouse genomic DNA extracted from the
animals tail. The PCR product was digested with Xba I and Xho I
restriction enzymes (New England BioLabs) and ligated into
previously Xba I and Xho I – digested pET303/CT-His
(InvitrogenH) plasmid. Plasmid DNA production was then
performed using E. coli DH10B-T1 cells (InvitrogenH). For
expression, freshly transformed cells (E. coli BL21 Star(DE3) cells,
InvitrogenH) were grown in 5 ml of Terrific Broth medium
supplemented with carbenicillin (100 ug/ml) at 37uC for 6 h. The
starter culture was then diluted into 50 ml of the same medium
and grown for another 6 h. This culture was finally diluted into
750 ml of the same medium and grown until it reached 0.7 OD.
One millimolar IPTG (isopropyl b-D-thiogalactopyranoside) was
then added, and the cells were induced for 5 h. The culture was
harvested by centrifugation and stored at 280uC. For purification,
cell pellets were thawed and resuspended in buffer A (50 mM Tris-
HCl, pH 8.0, 1 mM EDTA, and 100 mM NaCl). Cells were lysed
by adding 0.5 mg/ml lysozyme and subsequently sonicated. The
released inclusion bodies were pelleted by centrifugation at
22,000 g and then washed twice with buffer A supplemented with
0.05% (v/v) Triton X-100. The inclusion bodies containing recPrP
were solubilized for 2 hrs with buffer B (10 mM Tris-HCl,
100 mM Na2HPO4, pH 8.0, 100 mM NaCl, 10 mM -mercap-
toethanol, 6 M GdnCl) and then purified by using standard
immobilized metal affinity chromatography procedure. Briefly, the
sample was bound to Ni Sepharose 6 Fast Flow resin (GE
Healthcare) in batch mode for 1 hrs at room temperature and
then washed with buffer B. RecPrP was on-column refolded for
6 hrs and eluted with buffer B supplemented with 500 mM
imidazole and without GdnCl. The main peak was collected and
quickly filtered to remove aggregates. The sample was buffer
exchanged using Zeba desalting columns (PierceH), further
concentrated to ,0.5 mg/ml, and flash-frozen at 280uC.
Protease inhibitors (CompleteH protease inhibitor mixture from
Roche) were used throughout the purification to minimize
degradation. The protein was confirmed to be monomeric and
folded by SDS-PAGE, Western blotting, and circular dichroism.
The concentration of recPrP was estimated by spectrophotometry
using the BCA kit following manufacturer’s specifications and
confirmed by amino acid analysis.
Brain-derived PrP
Sc purification
The protease-resistant core of PrP
Sc (PrP27-30) used in this work
was obtained from RML-infected mouse brains and was purified as
follows: 10% brain homogenates containing 10% sarkosyl were
loaded onto a 20% sucrose cushion and centrifuged at 150,0006g
for 3 hrs. The pellet was resuspended in Z3-14 zwitterion detergent,
then loaded onto 20% sucrose cushion and centrifuged at 150,0006
g for 3 hrs. This step was repeated twice. Pellet was finally
resuspended in 1X PBS buffer and washed twice using the same
20% sucrose cushion. The PBS-resuspended pellet was further
digested by 50 mg/mL PK for 2 hrs at 37uC and then collected by
ultracentrifugation at 100.0006 g for 30 hrs. This last step was
repeated twice. The resulting PrP27-30 sample was shown to be
highly pure (.90%) as assessed by silver staining and western
blotting.PrP27-30 concentrationwasestimatedbyWesternBlotting
compared to known concentrations of soluble recPrP.
Aggregation assays
All reactions were carried out in 0.5 mL Lo-Bind Eppendorf
tubes (protease/nuclease free grade and further autoclaved). All
reagents were of highest available quality and protease-free grade
when available. Protease-free nanopure water was used to prepare
all master solutions and reactions. Thawing of recPrP was followed
by filtration through 100 kDa-cutoff Microcon tubes (Millipore) to
remove possible aggregates formed upon thawing. Protein
concentration was re-estimated upon filtration by spectrophotom-
etry. RecPrP (0.1 mg/mL final concentration) was mixed with
40 mM Hepes pH 7.2 and different concentrations of salts in
100 uL final volume reactions. pH was re-adjusted upon salt
addition. Aggregation experiments were conducted using a
protocol adapted from a previous report [61]. Unless specified,
reactions were placed in an Eppendorf Thermomixer for 24 hrs at
37uC with cycles of 1 minute agitation at 1500 rpm and 1 minute
incubation. Samples were then treated with Proteinase K (PK) at a
1/10 molar ratio (PK/recPrP) for 1 hrs at 37uC in a water bath,
unless specified differently. Analysis of digestion assays was
performed by SDS-PAGE followed by Western blotting and silver
staining. Antibodies 6D11 and M-20 were used for the analysis.
To determine the amount of aggregated protein, a 24 hrs reaction
was centrifuged at 300006 g for 30 min at 4uC. The pellet was
resuspended in 6 M GdmCl and boiled for 10 min at 95uC.
Protein concentration was estimated by spectrophotometry.
Thioflavin-T binding assay
Highly pure thioflavin-T (Th-T) dye stock solution was added
directly to reactions to a final concentration of 10 mM in black-
walled 96-well plates. Fluorescence measurements of the samples
were taken using a Microplate Reader Accessory adapted to a
Hitachi Fluorescence Spectrophotometer F-7000, using an
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range between 400 and 600 nm. A scan speed of 240 nm/min was
used as standard for all readings. To reduce interference noise
from excitation light, a 475 nm emission cutoff filter was used.
Fourier-Transform Infrared spectroscopy (FTIR)
FTIR experiments were conducted in an FT/IR-4100 spec-
trometer from JASCO. Monomeric recPrP was directly used as
control sample. RecPrP aggregates were formed after a 24 hrs
reactions in the presence of 400 mM NH4F, as described
previously. Before measurements, recPrP aggregates were PK-
treated at 37uC for 1 hr at 1/10 PK/recPrP ratio. The reaction
was stopped by adding 5 mM Pefabloc (RocheH) and then
concentrated by ultracentrifugation at 150,0006 g for 1 hrs at
4uC. Protein slurry was then added on top of a diamond PRO450-
S Attenuated Total Reflectance unit from JASCO adapted to the
FT/IR-4100 system. System parameters included 4.0 cm
21
resolution and an accumulation of 64 scans per sample. Data
fitting and secondary structure calculations of samples were
analyzed by multi-component analysis through the Secondary
Structure Estimation (SSE) software from JASCO. Each sample
measurement was optimized until the corrected experimental data
and the fitting curve gave minimum absorbance differences.
Negative staining Transmission Electron Microscopy
(TEM)
The same recPrP aggregates and PrP27-30 used for FT-IR
analysis were directly put onto FORMVAR–coated copper grids,
air-dried for 5 minutes followed by filter-paper-drying of reaction
excess. Grids with samples were negatively stained with 1% uranyl
acetate for 1 min, wick off excess and dry for another 5 min at
70uC. Imaging was performed on a JEOL 1200 transmission
electron microscope at 60 kV and captured by 1 k61 k Gatan
BioScan 792 CCD camera.
Cell Viability Assay
N2A cells were cultured in DMEM supplemented with 10%
fetal calf serum and antibiotics (10,000 U/ml Penicillin, 10 mg/ml
streptomycin), at 37uC and 5% CO2. For cell viability analysis,
cells were grown in collagen IV coated 96-well plates for 48 hrs in
cell culture medium containing 1% serum before addition of
recPrP aggregates and control reactions. Cell viability was
quantified using 3-(4,5-dimethylthazol-2-yl)-5-3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazine
methosulfate (PMS) according to the recommendations of the
supplier (Roche).
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